Medicare Will Not Cover GLP-1 Drugs for Weight Loss
The Centers for Medicare and Medicaid Services recently announced—without explanation—that it would not proceed with a proposal initiated by the Biden Administration to cover weight-loss drugs like Wegovy and Zepbound for its beneficiaries. Medicare and Medicaid recipients can be reimbursed for the medications to treat diabetes, but currently the anti-obesity versions of these drugs will … Read more